1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Palacaparib (AZD9574): new trials by email Literature Review of Palacaparib (AZD9574) trials Research Report on Palacaparib (AZD9574)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer AZD2265 (FPI-2265), Palacaparib (AZD9574), Docetaxel - Metastatic Prostate Cancer | Phase 1 / Phase 2 | Recruiting | AstraZeneca | 152 | 2026-06-03 | 2026-10-14 |
AstraZeneca (1)
Australia (1) · Germany (1) · Italy (1) · South Korea (1) · Spain (1) · United Kingdom (1) · United States (1)
2025 (1)